Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LB4330 / L&L Biopharma
TRIGGERCD8, NCT06468358: A Study to Evaluate LB1410 in Combination With LB4330 in Patients With Advanced or Metastatic Solid Tumors	Recruiting	1/2	194	RoW	LB1410, LB4330	L & L biopharma Co., Ltd., Shanghai China, Shanghai East Hospital	Solid Tumor	12/26	12/27
MEETCD8-001, NCT05707676: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors（）	Recruiting	1	66	RoW	LB4330	L & L biopharma Co., Ltd., Shanghai China	Solid Tumor	09/25	09/26